INS and type 2 diabetes mellitus: For example, Katogiannis et al. showed that decreased LAS was improved in metformin-treated patients with type 2 diabetes after 6-month-long treatment with liraglutide, empagliflozin or their combination (compared to insulin therapy) [13].